-
Safety and Tolerability of Different Total Neoadjuvant Therapies in Patients With Locally Advanced Rectal Cancer
-
Role of Radiotherapy in Liver Tumors: Recent Update
-
Advances in Phase III Clinical Trials and Future Challenges of Targeted Therapy in Advanced Ovarian Cancer
-
MRI‐based qualitative, quantitative, and radiomics/deep learning methods for assessing treatment response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
-
Correction to “Macro Habitat‐Based T2‐Weighted MRI Radiomics and Deep Learning Fusion for Predicting Treatment Response and Prognosis After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer”
-
lncRNA HOTAIR in Cancer: Recent Advances and Critical Perspectives on Molecular Mechanisms
-
The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial
-
A Systematic Review on Dostarlimab-gxlyin in the Treatment of Rectal Cancer: Efficacy, Safety, and Future Directions
-
Clinical trial enrollment of adolescent and young adult patients with cancer: a systematic review of the literature and proposed solutions
-
Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study
-
Clinical Factors Associated With Non‐Completion of Durvalumab Maintenance Therapy After Chemoradiotherapy in Patients With Locally Advanced Non‐Small Cell Lung Cancer: A Single‐Center Retrospective Study
-
Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review
-
Withstanding the test of time for patients in oncology clinical trials
-
HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies
-
Patient, care partner, and oncologist perspectives on clinically important survival thresholds after considering time toxicity in advanced cancer
-
Development and Validation of a Nomogram Integrating Body Composition and Inflammatory Markers to Predict Concurrent Chemoradiotherapy Response in Locally Advanced Cervical Cancer
-
Modernizing disease assessment in prostate cancer trials: the Prostate Cancer Working Group 4 framework
-
Clinical Utility of Comprehensive Genomic Profiling for Advanced Non‐Small Cell Lung Cancer: A Single‐Center Retrospective Study
-
Advances in the Treatment of Breast Cancer at Different Stages of Pregnancy
-
Retrospective Analysis of HER2 Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC With HER2 Mutations in France
-
Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
-
Physical activity and systemic treatment outcomes in advanced thyroid cancer
-
EGFR Mutations and Recurrence Outcomes in Resected Non‐Small Cell Lung Cancer: An Updated 2015–2025 Systematic Review and Meta‐Analysis
-
The clinical impact of androgens in endometrial cancer: cancer promoter or suppressor?
